Stay updated on Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the prior notices about government funding lapse and Revision: v3.4.1 were removed. These are minor site versioning updates with no impact on study content.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding lapse notice indicating possible data staleness and processing delays, with links to cc.nih.gov and opm.gov. Updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now shows a glossary, adds a 'Last Update Submitted that Met QC Criteria' indicator, and updates footer to Revision: v3.4.0, while removing the older 'Last Update Submitted that met QC Criteria' label, the 'No FEAR Act data' label, and the v3.3.4 revision reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section now includes a comprehensive list of participating sites by state and country (US states, Australia, United Kingdom, etc.). The previous location blocks (e.g., Alabama Locations, California Locations) were replaced under revision v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive study details appear to have changed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.